accountStock quotes in this article:TEVA Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the US Food and Drug Administration (FDA) has granted approval for the Company���s Abbreviated New Drug Application (ANDA) to market a generic...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Teva Announces Approval Of Generic Combivir Tablets: Launch Expected In Fourth Quarter 2011
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account